Antimicrobial resistance (AMR) happens when microorganisms survive exposure to a medicine that would normally kill them such as antibiotics, antimalarials and antivirals. These microorganisms are often referred to as ‘superbugs’ and can leave medicines ineffective. To learn more about AMR click here.
The World Health Organisation has stated that ‘new resistance patterns are emerging and spreading globally, threatening our ability to treat common infectious diseases, resulting in prolonged illness, disability, and death.’
The Fleming Fund is a UK Government aid programme to help low and middle income countries address priorities in tackling antimicrobial resistance (AMR), through a diverse range of projects. The Fleming Fund is led by the UK Department of Health and Social Care (DHSC) and delivered through a number of key partners.
The aim of the Fleming Fund is to support countries in collecting relevant high quality data that is shared nationally and globally. This will enable us collectively to better understand the scale and scope of the problem in order to effectively tackle the issue.